Streetbeat News

Analyst Ratings

MRVL

Investors are showing a bullish stance on Marvell Technology (NASDAQ:MRVL) with significant options trades. Benzinga's options scanner detected 12 unusual trades, with 66% bullish sentiment. Analysts maintain positive ratings, with price targets ranging from $85 to $120.

Portfolio Pulse from Benzinga Insights

September 18, 2024 | 2:48 pm

OXY

UBS analyst Josh Silverstein maintains a Neutral rating on Occidental Petroleum (NYSE:OXY) and lowers the price target from $70 to $59.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 2:46 pm

OVV

UBS analyst Josh Silverstein maintains a Buy rating on Ovintiv (NYSE:OVV) but lowers the price target from $61 to $57.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 2:42 pm

AMBC

Ambac Financial Group's shares have risen by 10% recently as the company plans to sell its financial guarantee business by year-end. Analyst Harry Fong upgraded the stock to 'Buy' with a price target of $15, citing potential cash earnings and a $50 million share repurchase program post-sale.

Portfolio Pulse from Priya Nigam

September 18, 2024 | 2:38 pm

MUR

UBS analyst Josh Silverstein maintains a Neutral rating on Murphy Oil (NYSE:MUR) and lowers the price target from $45 to $39.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 2:37 pm

MRO

UBS analyst Josh Silverstein maintains a Neutral rating on Marathon Oil (NYSE:MRO) and lowers the price target from $30 to $28.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 2:35 pm

HES

UBS analyst Josh Silverstein maintains a Buy rating on Hess (NYSE:HES) but lowers the price target from $192 to $173.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 2:33 pm

TTD

Trade Desk (NASDAQ:TTD) has seen significant options activity, with over 8 transactions totaling $328,214. The stock is currently priced at $108.39, up 2.4%, with a consensus target price of $119. Analysts have mixed ratings, with some downgrades and a few maintaining their Buy ratings.

Portfolio Pulse from Benzinga Insights

September 18, 2024 | 2:31 pm

ISRG

Intuitive Surgical (NASDAQ:ISRG) has seen a bearish sentiment from large investors, with 60% of recent options trades being bearish. The stock is currently trading at $480.82, with analysts setting an average price target of $527.0. The next earnings report is due in 29 days.

Portfolio Pulse from Benzinga Insights

September 18, 2024 | 2:31 pm

HAL

UBS analyst Josh Silverstein maintains a Buy rating on Halliburton but lowers the price target from $41 to $37.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 2:31 pm